KDM1A and breast cancer: Specifically, the KDM5B/LSD1/NuRD complex binds to the CCL14 promoter and suppresses its transcription by reducing H3K4 methylation levels, thus effectively inhibiting the invasive ability of BC cells and angiogenesis in vivo.